Multitrend Indo Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Multitrend Indo Tbk trades at Rp174 (market cap 485.32B, 589.3K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,500 (market cap 11.36T, 200K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 23.4× Multitrend Indo Tbk's market cap, and Multitrend Indo Tbk is more actively traded (589.3K versus 200K). Which is the better fit depends on your goals.
| BABY | TSPC | |
|---|---|---|
Market Cap | 485.32B | 11.36T |
Volume | 589.3K | 200K |
Lot | 5.89K | 2K |
Turnover | 101.82M | 500.06M |
Average Price | 172.78 | 2,500.28 |
Value | 101.82M | 500.06M |
Indicative Equilibrium Price | 174 | 2,500 |
Indicative Equilibrium Volume | 60 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Multitrend Indo Tbk ("Company") was established based on notary deed Drs. Wijanto Suwongso, SH, No. 20 dated September 7, 2004 and has beeen approved by the Ministry of Justice and Human Rights of Republic of Indonesia in its Decision Decree No. C-25996 HT.01.01.TH.2004 dated October 19 2004, and announced in the State Gazette No. 96 dated November 30, 2004, Supplement to the State Gazette of the Republic of Indonesia No. 11708. The Company started its commercial operations in 2004. PT Kanmo Retailindo are the parent entity and the ultimate parent of the Company.
Read more on BABY →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →